Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v5-FR | Version v2-FR | |
---|---|---|
Language | French | French |
Date Updated | 2018-10-22 | 2018-07-06 |
Drug Identification Number | 00131237 | 00131237 |
Brand name | CONRAY 60 | CONRAY 60 |
Common or Proper name | Iothalamate Meglumine Injection 60 % | Iothalamate Meglumine Injection 60 % |
Company Name | LIEBEL-FLARSHEIM COMPANY LLC | LIEBEL-FLARSHEIM COMPANY LLC |
Ingredients | IOTHALAMATE MEGLUMINE | IOTHALAMATE MEGLUMINE |
Strength(s) | 600MG | 600MG |
Dosage form(s) | SOLUTION | SOLUTION |
Route of administration | INTRAVASCULAR | INTRAVASCULAR |
Packaging size | 50 mL | 50 mL |
ATC code | V08AA | V08AA |
ATC description | X-RAY CONTRAST MEDIA, IODINATED | X-RAY CONTRAST MEDIA, IODINATED |
Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
Anticipated start date | ||
Actual start date | 2018-07-06 | 2018-07-06 |
Estimated end date | 2018-11-06 | 2018-11-06 |
Actual end date | 2018-10-22 | |
Shortage status | Actual shortage | Anticipated shortage |
Tier 3 Status | No | No |
Company comments | Reason for Shortage: Change of Manufacturing site | Reason for Shortage: Change of Manufacturing site |
Health Canada comments |